Zynex announces 2021 first quarter earnings

Englewood, colo., april 29, 2021 /prnewswire/ -- 2021 first quarter revenue increased 58% year over year to $24.1 million orders increased 140% net loss of $0.7 million; gaap loss per share $0.02 adjusted ebitda loss $0.4 million zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended march 31, 2021.
ZYXI Ratings Summary
ZYXI Quant Ranking